The GFPT1 Gene Myasthenia Congenital with Tubular Aggregates 1 genetic test is a specialized diagnostic procedure available at DNA Labs UAE. This test is designed to identify mutations in the GFPT1 gene, which have been linked to a rare form of congenital myasthenia. Congenital myasthenia is a group of conditions that result in muscle weakness and fatigue, often from birth. The specific subtype associated with mutations in the GFPT1 gene is characterized by the presence of tubular aggregates in muscle cells, which can be observed under a microscope.
The test involves collecting a DNA sample, typically through a blood draw, and analyzing it for specific genetic variations in the GFPT1 gene that are known to cause the condition. This genetic testing is crucial for the accurate diagnosis and management of patients with suspected congenital myasthenia, as it helps in tailoring the most effective treatment strategies for the individual.
At DNA Labs UAE, the cost of the GFPT1 Gene Myasthenia Congenital with Tubular Aggregates 1 genetic test is 4400 AED. This price includes the full testing procedure and a comprehensive report of the findings. By opting for this test, patients and their families can gain valuable insights into their genetic makeup, enabling them to make informed decisions about their health and care plans.
The MUSK Gene Myasthenic Syndrome Associated with Acetylcholine Receptor Deficiency Genetic Test is a specialized diagnostic tool designed to identify mutations in the MUSK gene, which are associated with a rare form of myasthenia gravis. This condition is characterized by muscle weakness and fatigue, primarily caused by an impairment in the transmission of signals between nerves and muscles. Unlike the more common forms of myasthenia gravis that involve antibodies against the acetylcholine receptor (AChR), this syndrome involves antibodies that target the muscle-specific kinase (MuSK), leading to a reduction in AChR at the neuromuscular junction.
The test, which costs 4400 AED, is available at DNA Labs UAE, a facility known for its advanced genetic testing capabilities. Through a detailed analysis of the patient's DNA, the test aims to identify any genetic alterations in the MUSK gene that may contribute to the development of this syndrome. The results can provide crucial information for the accurate diagnosis and tailored treatment of affected individuals, potentially improving their quality of life by managing symptoms more effectively. Given the complexity and rarity of this condition, the genetic test represents a significant step forward in the personalized medicine approach to treating neuromuscular disorders.
The SCN4A gene myasthenic syndrome is a rare genetic condition characterized by muscle weakness and fatigue. This condition is caused by mutations in the SCN4A gene, which plays a crucial role in the normal functioning of muscle cells. The SCN4A gene encodes a component of sodium channels that are essential for the transmission of electrical signals in muscle cells, facilitating muscle contraction. Mutations in this gene can disrupt the normal flow of sodium ions, leading to the symptoms associated with the syndrome.
To diagnose this condition, a specific genetic test is available that identifies mutations in the SCN4A gene. This test is crucial for confirming the diagnosis, understanding the severity of the condition, and guiding treatment decisions. The test involves collecting a DNA sample, usually through a blood draw, and analyzing the genetic material for mutations in the SCN4A gene.
In the United Arab Emirates, this genetic test is offered by DNA Labs UAE, a reputable facility known for its advanced diagnostic services. The cost of the SCN4A gene myasthenic syndrome genetic test at DNA Labs UAE is 4400 AED. This test is a valuable tool for individuals experiencing symptoms of muscle weakness and fatigue, providing them with a definitive diagnosis and enabling them to seek appropriate treatment and management strategies for their condition.
The POLG gene mitochondrial neurogastrointestinal encephalopathy syndrome without leukoencephalopathy genetic test is a specialized diagnostic tool available at DNA Labs UAE. Priced at 4400 AED, this test focuses on identifying mutations in the POLG gene, which are associated with a rare condition known as mitochondrial neurogastrointestinal encephalopathy (MNGIE) syndrome. Unlike the typical form of MNGIE, this specific testing is aimed at cases where leukoencephalopathy, or white matter brain disease, is not present, making it a crucial tool for accurate diagnosis in such unique circumstances. The POLG gene plays a significant role in the replication and repair of mitochondrial DNA; mutations in this gene can lead to various mitochondrial disorders, including MNGIE. This test is essential for guiding treatment strategies and understanding the prognosis for affected individuals.
The TYMP gene mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE) without leukoencephalopathy genetic test is a specialized diagnostic procedure offered by DNA Labs UAE. This test is designed to detect mutations in the TYMP gene, which are responsible for a rare condition known as mitochondrial neurogastrointestinal encephalopathy syndrome (MNGIE) without the characteristic white matter brain changes typically seen in this disorder, known as leukoencephalopathy. MNGIE is a progressive, autosomal recessive metabolic disorder characterized by a range of symptoms including gastrointestinal dysmotility, peripheral neuropathy, ptosis, and progressive external ophthalmoplegia, among others.
The absence of leukoencephalopathy in some patients can make diagnosis challenging, necessitating the use of genetic testing to confirm the presence of TYMP gene mutations. The test involves analyzing the patient's DNA, extracted from a blood sample, to identify mutations in the TYMP gene that are indicative of MNGIE.
At DNA Labs UAE, this comprehensive genetic test is offered at a cost of 4400 AED. It is a critical tool for healthcare professionals in diagnosing MNGIE without leukoencephalopathy, allowing for appropriate management and treatment plans to be devised based on the genetic findings. The test is conducted with strict confidentiality and precision, ensuring patients receive accurate and actionable results.
The SDHA gene plays a crucial role in the mitochondrial respiratory chain, specifically in Complex II, which is vital for energy production within cells. Deficiencies in Complex II can lead to a range of serious genetic disorders, including Leigh syndrome, cardiomyopathy, and mitochondrial encephalomyopathy. These conditions can manifest as neurological deficits, muscle weakness, heart problems, and metabolic disturbances.
The SDHA Gene Mitochondrial Respiratory Chain Complex II Deficiency Genetic Test is a specialized diagnostic tool used to identify mutations in the SDHA gene. By analyzing an individual's DNA, this test can confirm or rule out the presence of genetic abnormalities affecting Complex II, assisting in the diagnosis, management, and treatment planning for affected patients.
This test is available at DNA Labs UAE, a leading facility in genetic diagnostics. The cost of the test is 4400 AED. DNA Labs UAE utilizes state-of-the-art technology and employs a team of genetic experts to ensure accurate and reliable results. This test is crucial for families with a history of mitochondrial or metabolic disorders, providing essential information for genetic counseling and decision-making regarding family planning.
The TIMM21 gene plays a crucial role in the proper functioning of the mitochondrial respiratory chain, which is essential for energy production in cells. Mutations in the TIMM21 gene can lead to mitochondrial respiratory chain diseases, which are a group of disorders that affect the mitochondria's ability to produce energy efficiently. These diseases can have a wide range of symptoms and can affect multiple organs and systems in the body.
To diagnose and understand the specific genetic mutations in the TIMM21 gene, genetic testing is available. The TIMM21-related genetic test is a specialized diagnostic tool designed to identify mutations in the TIMM21 gene that may be responsible for mitochondrial respiratory chain diseases. This test is crucial for confirming the diagnosis, understanding the disease's progression, and guiding treatment options.
The test is available at DNA Labs UAE, a leading facility specializing in genetic and molecular diagnostics. The cost of the TIMM21-related genetic test is 4400 AED. This investment in testing can provide essential information for affected individuals and their families, enabling them to make informed decisions about their health and treatment plans.
The ECHS1 gene encodes the mitochondrial enzyme short-chain enoyl-CoA hydratase 1, which plays a critical role in the metabolism of fatty acids and amino acids. Mutations in the ECHS1 gene can lead to a deficiency in this enzyme, resulting in a range of metabolic disorders. These disorders are often characterized by developmental delay, epilepsy, lactic acidosis, and cardiomyopathy, among other symptoms. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals.
The genetic test for ECHS1 gene mitochondrial short-chain enoyl-CoA hydratase 1 deficiency is a specialized diagnostic tool designed to detect mutations in the ECHS1 gene. This test is vital for confirming the diagnosis, understanding the disease's progression, and guiding treatment options. It involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in a laboratory to identify any mutations in the ECHS1 gene.
In the UAE, this specific genetic test is available at DNA Labs UAE, a leading provider of genetic testing services in the region. The cost of the test is set at 4400 AED. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in the field of genetic testing, ensuring accurate and reliable results. This test is an important resource for families and individuals at risk of or showing symptoms of ECHS1 deficiency, providing them with essential information for managing the condition.
The ANO5 Gene Miyoshi Muscular Dystrophy Type 3 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to detect mutations in the ANO5 gene, which are linked to the development of Miyoshi Muscular Dystrophy Type 3 (MMD3). This form of muscular dystrophy is a rare genetic disorder characterized by muscle weakness and atrophy, primarily affecting the muscles of the lower limbs. The test plays a crucial role in confirming the diagnosis, enabling early intervention, and allowing for better management of the condition. Priced at 4400 AED, the test involves analyzing the patient's DNA to identify any genetic alterations in the ANO5 gene, providing valuable information for affected individuals and their families regarding the prognosis and potential genetic counseling needs. DNA Labs UAE, known for its advanced genetic testing capabilities, offers this comprehensive service, ensuring accuracy and reliability in the results.
DYSF Gene Miyoshi Myopathy Genetic Test is a specialized diagnostic examination aimed at identifying mutations in the DYSF gene, which are responsible for Miyoshi Myopathy. Miyoshi Myopathy is a type of muscular dystrophy characterized by muscle weakness and atrophy, primarily affecting the distal muscles of the legs and arms. This genetic disorder is inherited in an autosomal recessive manner, meaning that two copies of the mutated gene, one from each parent, are required for the condition to manifest.
The test is performed at DNA Labs UAE, a leading facility in genetic diagnostics, ensuring high accuracy and reliability. By analyzing a patient's DNA sample, usually obtained through a blood draw, the test can pinpoint specific mutations in the DYSF gene, confirming a diagnosis of Miyoshi Myopathy. This is crucial for the development of a tailored treatment plan and for providing genetic counseling to affected individuals and their families.
The cost of the DYSF Gene Miyoshi Myopathy Genetic Test at DNA Labs UAE is 4400 AED. While the price may seem significant, the test offers invaluable insights into the genetic basis of the condition, facilitating early intervention and management strategies that can significantly improve the quality of life for those affected.
